| EARNINGS PER SHARE |
NOTE
13. EARNINGS PER SHARE
The
following table presents the computation of basic and diluted net loss per common share:
SCHEDULE
OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three Months Ended | | |
For the Nine Months Ended | |
| | |
March 31, | | |
March 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Numerator: | |
| | |
| | |
| | |
| |
| Net loss | |
$ | (12,683,231 | ) | |
$ | (1,502,202 | ) | |
$ | (14,942,129 | ) | |
$ | (2,490,522 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average common shares outstanding for basic and diluted net loss per share | |
| 21,076,506 | | |
| 20,999,445 | | |
| 21,072,444 | | |
| 19,161,661 | |
| | |
| | | |
| | | |
| | | |
| | |
| Basic and diluted net loss per share | |
$ | (0.60 | ) | |
$ | (0.07 | ) | |
$ | (0.71 | ) | |
$ | (0.13 | ) |
Potentially
dilutive securities, on a weighted average basis, that were not included in the calculation of diluted net loss per share attributable
to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):
SCHEDULE
OF ANTI_DILUTIVE POTENTIALLY DILUTIVE SECURITIES
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three Months Ended | | |
For the Nine Months Ended | |
| | |
March 31, | | |
March 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Options | |
| 4,706,125 | | |
| 4,977,117 | | |
| 4,672,317 | | |
| 5,340,569 | |
| Warrants | |
| 737,500 | | |
| 788,167 | | |
| 737,500 | | |
| 838,741 | |
| Total | |
| 5,443,625 | | |
| 5,765,284 | | |
| 5,409,817 | | |
| 6,179,310 | |
Stock
options above include 1,980,000 executive Target Options as of March 31, 2026 and 2025, respectively. Vesting of these is considered
remote.
|